Identification of novel lncRNAs involved in the pathogenesis of childhood acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of novel lncRNAs involved in the pathogenesis of childhood acute lymphoblastic leukemia

Published:2018-12-14 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Li Sheng¹,Bian Hongliang²,Cao Yizhi³,Juan Chenxia¹,Cao Qian¹,Zhou Guoping¹,Fang Yongjun⁴

Affiliation:

1. Department of Pediatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China

2. Department of Pediatrics, Yancheng Maternity and Child Health Care Hospital, Yancheng, Jiangsu 224000, P.R. China

3. The First Clinical Medical School of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China

4. Department of Hematology and Oncology, The Affiliated Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNA expression in acute lymphoblastic leukemia: A systematic review;Critical Reviews in Oncology/Hematology;2024-04

2. Long Non-Coding RNA Signatures in Lymphopoiesis and Lymphoid Malignancies;Non-Coding RNA;2023-08-01

3. Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potential;Molecular Aspects of Medicine;2022-12

4. Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment;International Journal of Molecular Sciences;2022-04-18

5. Targeting the lncRNA DUXAP8/miR-29a/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia;Frontiers in Oncology;2022-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3